Diagnostic Potential of Urinary α1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer
Abstract
Purpose:
The ability to reliably diagnose bladder cancer in voided urine samples would be a major advance. Using high throughput technologies, we identified a panel of bladder cancer associated biomarkers with potential clinical usefulness. In this study we tested 4 potential biomarkers for the noninvasive detection of bladder cancer.
Materials and Methods:
We examined voided urine specimens from 124 patients, including 63 newly diagnosed with bladder cancer and 61 controls. Concentrations of proteins were assessed by enzyme-linked immunosorbent assay, including α1-antitrypsin, apolipoprotein E, osteopontin and pentraxin 3. Data were compared to the results of urinary cytology and the BTA Trak® enzyme-linked immunosorbent assay based bladder cancer detection assay. We used the AUC of ROC curves to compare the usefulness of each biomarker to detect bladder cancer.
Results:
Urinary levels of α1-antitrypsin, apolipoprotein E and bladder tumor antigen were significantly increased in subjects with bladder cancer. α1-Antitrypsin (AUC 0.9087, 95% CI 0.8555–0.9619) and apolipoprotein E (AUC 0.8987, 95% CI 0.8449–0.9525) were the most accurate biomarkers. The combination of α1-antitrypsin and apolipoprotein E (AUC 0.9399) achieved 91% sensitivity, 89% specificity, and a positive and negative predictive value of 89% and 90%, respectively. Multivariate regression analysis highlighted only apolipoprotein E as an independent predictor of bladder cancer (OR 24.9, 95% CI 4.22–146.7, p = 0.0004).
Conclusions:
Alone or in combination, α1-antitrypsin and apolipoprotein E show promise for the noninvasive detection of bladder cancer (OR 24.9, 95% CI 4.22–146.7, p = 0.0004). Larger, prospective studies including more low grade, low stage tumors are needed to confirm these results.
References
- 1 : Cancer statistics, 2012. CA Cancer J Clin2012; 62: 10. Google Scholar
- 2 : Urine cytology of transitional cell neoplasms. Urol Clin North Am1979; 6: 599. Crossref, Medline, Google Scholar
- 3 : Usefulness of the BTA STAT Test for the diagnosis of bladder cancer. Urology2001; 57: 685. Google Scholar
- 4 : Use of the NMP22 BladderChek test in the diagnosis and follow-up of urothelial cancer: a cross-sectional study. Urology2010; 77: 154. Google Scholar
- 5 : Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Cancer2007; 111: 517. Google Scholar
- 6 : Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia. Cancer Epidemiol Biomarkers Prev2009; 18: 444. Google Scholar
- 7 : Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res2007; 6: 2631. Google Scholar
- 8 : Urinary glycoprotein biomarker discovery for bladder cancer detection using LC-MS/MS and label-free quantification. Clin Cancer Res2011; 17: 3349. Google Scholar
- 9 : Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology2005; 66: 35. Google Scholar
- 10 : Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract2004; 21: 4. Google Scholar
- 11 : AJCC Cancer Staging Manual. American Joint Committee on Cancer, American Cancer Society New York: Springer-Verlag2002. Google Scholar
- 12 : The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol2005; 13: 143. Google Scholar
- 13 : Discovery of urinary biomarkers. Molec Cell Proteom2006; 5: 1760. Google Scholar
- 14 : Urinary excretion of creatinine in normal subjects. Chin Pharmaceut J1992; 44: 235. Google Scholar
- 15 : Estimation of the Youden Index and its associated cutoff point. Biom J2005; 47: 458. Google Scholar
- 16 : Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci U S A2011; 108: 14813. Google Scholar
- 17 : Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem2001; 276: 43455. Google Scholar
- 18 : Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet2000; 1: 507. Google Scholar
- 19 : The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression. DNA Cell Biol2011; 30: 851. Google Scholar
- 20 : An interaction between apolipoprotein E and TERE1 with a possible association with bladder tumor formation. J Cell Biochem2005; 95: 419. Google Scholar
- 21 : Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. Proteomics2012; 12: 135. Google Scholar
- 22 : Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab2010; 99: 157. Google Scholar
- 23 : Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. Clin Chim Acta2009; 404: 111. Google Scholar
- 24 : Protease inhibitor SERPINA1 expression in epithelial ovarian cancer. Clin Exp Metastasis2010; 27: 55. Google Scholar
- 25 : Spotlight on differentially expressed genes in urinary bladder cancer. PLoS One2011; 6: e18255. Google Scholar
- 26 : Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. Urol Oncol2011; 29: 703. Google Scholar
- 27 : Interleukin-1-inducible genes in endothelial cells: Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem1992; 267: 22190. Google Scholar
- 28 : Pentraxin-3 is a novel biomarker of lung carcinoma. Clin Cancer Res2011; 17: 2395. Google Scholar
- 29 : Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer2011; 18: 465. Google Scholar
- 30 : Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urol2009; 9: 12. Google Scholar
